Results 171 to 180 of about 6,619 (182)
Some of the next articles are maybe not open access.
Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
New England Journal of Medicine, 2013Donal J Sexton +2 more
exaly
Phase III Clinical Pharmacology Study of Tolvaptan
Cardiovascular Drugs and Therapy, 2011Atsushi Hirayama +2 more
exaly
Tolvaptan, an Orally Active Vasopressin V2-Receptor Antagonist—Pharmacology and Clinical Trials
Cardiovascular Drug Reviews, 2007Hiroyuki Fujiki +2 more
exaly
Predictive Factors for Responders to Tolvaptan in Fluid Management After Cardiovascular Surgery
General Thoracic and Cardiovascular Surgery, 2017Yoshiki Sawa +2 more
exaly
Tolvaptan in Later-Stage Polycystic Kidney Disease
New England Journal of Medicine, 2018Christian De Tymowski +2 more
exaly
Con: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease-Do We Know All the Answers?
Nephrology Dialysis Transplantation, 2019Alexander Paliege
exaly

